Thomas L. Schwartz – författare

Guiding clinicians toward the most effective treatment regimens, this reference offers detailed coverage of the symptomatology, diagnosis, epidemiology, and etiology of depression. A must-have tool for anyone prescribing psychotropics or performing psychotherapy, this source expertly reviews research and clinical data regarding acute and long-term outcomes, combination therapies, neuroimaging, genetics, and pharmacologic and psychotherapeutic measures to stand as the most complete layout of practices in the management of depression.

Practical Psychopharmacology, 2nd ed, takes the novel approach of writing at three different levels—beginning, intermediate, and advanced—to give the practicing psychopharmacologist a tailored experience.Each chapter focuses on a specific DSM-5TR disorder and outlines abbreviated treatment guidelines to help the reader understand where their knowledge base and clinical practice currently reside. At the first level, the book teaches novice prescribers practical diagnostic skills and provides a brief overview of pertinent genetic and neuroimaging findings to increase prescribing confidence. Next, it provides mid-level clinicians with intermediate techniques and guidelines for more difficult cases. The final level provides nuanced guidance for advanced practitioners or those who see the most treatment-resistant patients.This approach allows a clinician to access this book periodically throughout the care of an individual patient and to gradually progress through a series of more advanced psychopharmacological techniques for making accurate and efficient diagnoses.

Practical Psychopharmacology, 2nd ed, takes the novel approach of writing at three different levels—beginning, intermediate, and advanced—to give the practicing psychopharmacologist a tailored experience.Each chapter focuses on a specific DSM-5TR disorder and outlines abbreviated treatment guidelines to help the reader understand where their knowledge base and clinical practice currently reside. At the first level, the book teaches novice prescribers practical diagnostic skills and provides a brief overview of pertinent genetic and neuroimaging findings to increase prescribing confidence. Next, it provides mid-level clinicians with intermediate techniques and guidelines for more difficult cases. The final level provides nuanced guidance for advanced practitioners or those who see the most treatment-resistant patients.This approach allows a clinician to access this book periodically throughout the care of an individual patient and to gradually progress through a series of more advanced psychopharmacological techniques for making accurate and efficient diagnoses.

Guiding clinicians toward the most effective treatment regimens, this reference offers detailed coverage of the symptomatology, diagnosis, epidemiology, and etiology of depression. A must-have tool for anyone prescribing psychotropics or performing psychotherapy, this source expertly reviews research and clinical data regarding acute and long-term

This updated and revised Second Edition provides a state-of-the-science review and clinical collection of research on treating depression with multiple therapies. The text is an essential guide for those who prescribe psychotropics or perform psychotherapy, including psychiatrists, residents, psychologists, and psychopharmacologists. Containing res

Practical Psychopharmacology, 2nd ed, takes the novel approach of writing at three different levels-beginning, intermediate, and advanced-to give the practicing psychopharmacologist a tailored experience.Each chapter focuses on a specific DSM-5TR disorder and outlines abbreviated treatment guidelines to help the reader understand where their knowledge base and clinical practice currently reside. At the first level, the book teaches novice prescribers practical diagnostic skills and provides a brief overview of pertinent genetic and neuroimaging findings to increase prescribing confidence. Next, it provides mid-level clinicians with intermediate techniques and guidelines for more difficult cases. The final level provides nuanced guidance for advanced practitioners or those who see the most treatment-resistant patients.This approach allows a clinician to access this book periodically throughout the care of an individual patient and to gradually progress through a series of more advanced psychopharmacological techniques for making accurate and efficient diagnoses.

Following the success of the first collection of Stahl's Case Studies, published in 2011, we are pleased to present this completely new selection of clinical stories. Designed with the distinctive user-friendly presentation readers have become accustomed to and making use of icons, questions/answers and tips, these cases address complex issues in an understandable way and with direct relevance to the everyday experience of clinicians. Covering a wide-ranging and representative selection of clinical scenarios, each case is followed through the complete clinical encounter, from start to resolution, acknowledging all the complications, issues, decisions, twists and turns along the way. The book is about living through the treatments that work, the treatments that fail, and the mistakes made along the journey. This is psychiatry in real life - these are the patients from your waiting room - this book will reassure, inform and guide better clinical decision making. Optional posttests with CME credit are available for a fee (waived for NEI members). For more information, contact the Neuroscience Education Institute.

This new volume in Stahl's Case Studies series presents the continuation of Dr. Schwartz's previous successful collection of psychopharmacology cases from Volume 2, this time in collaboration with Dr. Radonjić and editing from Dr. Stahl. Here they illustrate common questions and dilemmas routinely encountered in psychopharmacologic day-to-day practice. Following a consistent user-friendly layout, each case features icons, tips, and questions about diagnosis and management as it progresses over time, a pre-case self-assessment question, followed by the correct answers at the end. Formatted in alignment with the American Board of Psychiatry and Neurology's maintenance of psychiatry specialty certification, cases address issues in a relevant and understandable way. Covering a wide-ranging and representative selection of clinical scenarios, each case is followed through the complete clinical encounter, from start to resolution, acknowledging the complications, issues, decisions, twists, and turns along the way. This is psychiatry in real life.

Following the success of the first collection of Stahl''s Case Studies, published in 2011, we are pleased to present this completely new selection of clinical stories. Designed with the distinctive user-friendly presentation readers have become accustomed to and making use of icons, questions/answers and tips, these cases address complex issues in an understandable way and with direct relevance to the everyday experience of clinicians. Covering a wide-ranging and representative selection of clinical scenarios, each case is followed through the complete clinical encounter, from start to resolution, acknowledging all the complications, issues, decisions, twists and turns along the way. The book is about living through the treatments that work, the treatments that fail, and the mistakes made along the journey. This is psychiatry in real life - these are the patients from your waiting room - this book will reassure, inform and guide better clinical decision making. Optional posttests with CME credit are available for a fee (waived for NEI members). For more information, contact the Neuroscience Education Institute.

Following the success of the first collection of Stahl''s Case Studies, published in 2011, we are pleased to present this completely new selection of clinical stories. Designed with the distinctive user-friendly presentation readers have become accustomed to and making use of icons, questions/answers and tips, these cases address complex issues in an understandable way and with direct relevance to the everyday experience of clinicians. Covering a wide-ranging and representative selection of clinical scenarios, each case is followed through the complete clinical encounter, from start to resolution, acknowledging all the complications, issues, decisions, twists and turns along the way. The book is about living through the treatments that work, the treatments that fail, and the mistakes made along the journey. This is psychiatry in real life - these are the patients from your waiting room - this book will reassure, inform and guide better clinical decision making. Optional posttests with CME credit are available for a fee (waived for NEI members). For more information, contact the Neuroscience Education Institute.

Guiding clinicians toward the most effective treatment regimens, this reference offers detailed coverage of the symptomatology, diagnosis, epidemiology, and etiology of depression. A must-have tool for anyone prescribing psychotropics or performing psychotherapy, this source expertly reviews research and clinical data regarding acute and long-term

This updated and revised Second Edition provides a state-of-the-science review and clinical collection of research on treating depression with multiple therapies. The text is an essential guide for those who prescribe psychotropics or perform psychotherapy, including psychiatrists, residents, psychologists, and psychopharmacologists. Containing research data, case studies, and expert recommendations, this source explores the best acute, long-term, and combination treatment strategies for superior patient care.

New to the Second Edition:

a chapter devoted to a simultaneous discussion on psychotherapy and pharmacotherapychapters on depression and anxiety, depression and pain, and new treatment optionsinformation on the advancements of genetics, imaging, and brain stimulation with regard to depressive disorders and implications for future usethe latest research on drug development and combining drug treatments

This updated and revised Second Edition provides a state-of-the-science review and clinical collection of research on treating depression with multiple therapies. The text is an essential guide for those who prescribe psychotropics or perform psychotherapy, including psychiatrists, residents, psychologists, and psychopharmacologists. Containing res

The second generation antipsychotics are a complex class of psychiatric medications, applicable to a diverse range of both FDA approved treatment indications and off-label uses. This variety stems largely from the unique pharmacodynamic profile of each agent, and often necessitates the employment of unique dosing strategies across the treatment of the varied psychiatry disorders, including schizophrenia, bipolar mania and depression, major depressive disorder, and autism. Despite the shared mechanism of dopamine D2 and serotonin-2a dual receptor blockade, which mediates the antipsychotic and antimanic properties of the second generation antipsychotics, the unique pharmacodynamic signature of each agent is subsequently responsible for the additional and varied antidepressant, anxiolytic, hypnotic, and tolerability profile observed with each drug. Using an evidence based approach, this comprehensive handbook aims to highlight and discuss data relevant to treatment indications, off-labels uses, and dosing strategies of the 11 currently FDA approved second generation antipsychotics, with a strong emphasis on the pharmacodynamic profiles of these drugs. With the advent of three relatively new antipsychotics (lurasidone in 2011, brexpiprazole in 2015, and cariprazine in 2015), this text will serve as an excellent reference for practicing physicians, research investigators, and medical students alike. This review addresses not only these clinical applications, but provides physicians with the tools necessary to optimize treatment based upon patient diagnosis, proper antipsychotic selection, and implementation of an appropriate dosing strategy, thereby striking an essential balance between treatment efficacy and patient tolerability.

Practical Psychopharmacology takes the novel approach of writing at three different levels—beginning, intermediate, and advanced—to give the practicing psychopharmacologist a tailored experience. Each chapter focuses on a specific DSM-5 disorder and outlines abbreviated treatment guidelines to help the reader understand where their knowledge base and clinical practice currently resides. At the first level, the book teaches novice prescribers practical diagnostic skills and provides a brief overview of pertinent genetic and neuroimaging findings to increase prescribing confidence. Next, it provides mid-level clinicians with intermediate techniques and guidelines for more difficult cases. The final level provides nuanced guidance for advanced practitioners or those who see the most treatment-resistant patients. This approach allows a clinician to access this book periodically throughout the care of an individual patient and to gradually progress through a series of more advanced psychopharmacological techniques for making accurate and efficient diagnoses. Readers can also visit the book’s eResource page to download a bonus chapter on eating disorders as well as case studies and multiple-choice questions for each chapter.